A tolerability, pharmacokinetics and phamacodynamics phase Ⅰclinical trial of intravenous infusions of Recombinant Neutrophil inhibitory factor and Hirulog Hbrid in healthy volunteers
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Neutrophil inhibitory factor-bivalirudin fusion protein (Primary)
- Indications Stroke
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Jun 2016 New trial record